Infection control strategy for COVID-19 at endoscopy unit in the era of COVID-19 outbreak
Digestive Medicine Research · 2020
DOI: 10.21037/dmr-20-122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Medicine Research, 2020. Verfasst von Takumi Onoyama und 4 weiteren Autor:innen.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
© Digestive Medicine Research. All rights reserved. Dig Med Res 2020;3:34 | http://dx.doi.org/10.21037/dmr-20-122 Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) related disease, known as coronavirus disease 2019 (COVID-19), has spread world over and has been declared a global pandemic by the World Health Organization (WHO) on 11th March, 2020. COVID-19 not only causes respiratory symptoms such as cough, fever, sputum production, and shortness of breath, but may also produce gastrointestinal symptoms including nausea, vomiting, and diarrhea (1). The rate of severe COVID-19 is 13.9%, with an overall mortality rate of 2.3% (2). SARS-CoV-2 is mainly transmitted through aerosols, droplets, and direct contact (3,4). Performing upper endoscopic procedures such as esophagogastroduodenoscopy (EGD), endoscopic ultrasonography (EUS), and endoscopic retrograde cholangiopancreatography (ERCP), can predispose endoscopists and medical staff to infection as aerosols may be generated by patients coughing, retching, or belching during the procedure. Furthermore, performing colonoscopy (CS) may also increase the risk of SARS-CoV-2 transmission as it has been detected in the fecal samples of infected subjects (5). Currently, some international guidance recommends essential steps, such as stringent patient triage (prescreening), endoscopic procedure stratification, and appropriate use of personal protective equipment (PPE) to prevent peri-procedural transmission of SARS-CoV-2 of endoscopic personnel and nosocomial infection between patients (6-10). We are conducting an infection control strategy (ICS) of our endoscopy unit according to those guidance, especially statements of the Asian Pacific Society for Digestive Endoscopy (APSDE) that greatly influenced our ICS (6). In addition, we have carried out several characteristic ICS in our endoscopy unit. This article aim is to summarize the ICS of APSDE for COVID-19 and to present the characteristic ICS of our endoscopy unit based on these statements.
Zitieren
APA
Onoyama, T., Teramoto, K., Kurumi, H., Fujii, M., & Isomoto, H. (2020). Infection control strategy for COVID-19 at endoscopy unit in the era of COVID-19 outbreak. Digestive Medicine Research. https://doi.org/10.21037/dmr-20-122
Vancouver
Onoyama T, Teramoto K, Kurumi H, Fujii M, Isomoto H. Infection control strategy for COVID-19 at endoscopy unit in the era of COVID-19 outbreak. Digestive Medicine Research. 2020. doi:10.21037/dmr-20-122
BibTeX
@article{Onoyama2020,
author = {Onoyama, Takumi and Teramoto, Kei and Kurumi, Hiroki and Fujii, Masashi and Isomoto, Hajime},
title = {Infection control strategy for COVID-19 at endoscopy unit in the era of COVID-19 outbreak},
journal = {Digestive Medicine Research},
year = {2020},
doi = {10.21037/dmr-20-122}
}
EUVIMED